February 23– Israeli scientists have uncovered a unique property in breast milk that aids in transporting essential nutrients from the stomach and intestines into the bloodstream, potentially paving the way for revolutionary advancements in oral medication and vaccinations. The discovery, detailed in the Journal of Controlled Release, suggests new possibilities for delivering antibodies, proteins like insulin, and vaccines for COVID-19 and the flu through oral administration, circumventing the need for injections.

Breaking the Barriers

Researchers were driven by the aim of finding ways to deliver vaccines and medications orally, seeking inspiration from breast milk. Breast milk is a complex substance rich in enzymes, hormones, antibodies, and lipids, all vital for a newborn’s brain development, immune system, and digestion.
Breast milk must navigate the intestinal barrier, a protective layer that separates the gut from the bloodstream. This barrier, composed of cells and mucus, functions like a sophisticated filter, blocking harmful substances while allowing nutrients to pass.

The study revealed that breast milk contains special “keys” — specific proteins — that help its components traverse this barrier. These proteins form a coating around tiny particles, called the “Human Breast Milk Protein Corona.” This coating allows the particles to pass through the intestinal barrier, with the efficiency of this process influenced by the electrical charge of the particles.

Scientific Validation

The researchers validated their findings using human intestinal cells and pig intestines, comparing breast milk to cow’s milk and baby formula. Notably, breast milk proved most effective in helping substances pass through the intestinal barrier.

The researchers reported the discovery in the Journal of Controlled Release.

Revolutionizing Medicines

This discovery could significantly impact the delivery of essential medications. For instance, insulin injections, a daily routine for millions of Americans with diabetes, could become a thing of the past. Similarly, oral vaccines for COVID-19 and flu shots, which currently require needles, could become more accessible and convenient, potentially improving vaccination rates and public health outcomes.

The implications for COVID-19 vaccine distribution are profound. Oral vaccines could eliminate the need for skilled healthcare workers to administer injections, making vaccination drives more efficient and reaching underserved communities more effectively.

Case Studies and Examples

Consider the scenario of a national influenza outbreak. With oral vaccines, community health workers could be trained to distribute and administer these vaccines widely, potentially reducing the spread of the disease. Similarly, in rural areas where access to healthcare is limited, oral medications could save countless lives by making essential treatments accessible.

Addressing Counterpoints

While the discovery is groundbreaking, skeptics might argue about the long-term stability of such drugs and the potential side effects. Researchers acknowledge the need for extensive clinical trials to ensure the long-term safety and effectiveness of these medications.

Addressing concerns about efficacy, the research team emphasizes that the natural properties of breast milk have already been proven effective in newborns. Extending these properties to oral medications should be achieved cautiously but promises high efficacy rates.

Looking Ahead

The next step involves integrating these findings into the pharmaceutical industry. Ongoing research could lead to new formulations that mimic the efficiency of human breast milk, setting the stage for a future where oral medications, including vaccines and insulin, become the norm. The global implications of this discovery are enormous, potentially transforming healthcare systems worldwide.